Last updated: 2026-09-16 10:31:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Apyx Medical Corporation (APYX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.97, with a market capitalisation of $127.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.70 to $5.08. This page covers its latest market performance, valuation, price trends and company information.
$127.21M | |
$3.03 | |
$17.50 | |
$0.76 | |
$3.02 | |
41.92K | |
113.04K | |
-- | |
$5.08 | |
$1.70 | |
-- | |
-- |
Apyx Medical Corporation (APYX) is trading at $3.02 in pre-market trading as of 2026-09-15 23:31:00, unchanged from the previous close of $3.02
Pre-market trading shows how investors are pricing APYX before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.
Over the past seven days, Apyx Medical Corporation (APYX) moved from $3.05 to $2.97, representing a decline of 2.66% ($0.08).
The stock traded between $2.79 and $3.08 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 92.35 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 37.5%
APYX is currently trading at $2.97, placing it 37.5% of the way from its 52-week low of $1.70 to its 52-week high of $5.08. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 205 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Apyx Medical Corporation (APYX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.